FDA Recall United States TerminatedTerminated: March 17, 2026Historical recordClass II
Reisman Bros Bakery
- Product
- Reisman's Chocolate Danishes 3 oz.
- Reason
- Undeclared wheat and soy
- Published
- August 6, 2025
- Distribution
- Multiple states
Data Explorer
Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.
Recall totals
All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.
37,271
Total recall recordsAll FDA and USDA recalls in Public Health Trace9,852
Class I recallsReasonable probability of serious health consequences24,397
Class II recallsTemporary or medically reversible health consequences2,897
Class III recallsNot likely to cause adverse health consequencesQuick insights
A snapshot of the most notable patterns across all recorded FDA and USDA recalls.
Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap.
53 recalls
Most common hazardLack of Assurance of Sterility
2,085 recalls
Newest recallhttps://www.fsis.usda.gov/recalls-alerts/kayem-foods-inc--recalls-meat-and-poultry-products-due-possible-temperature-abusePublished October 17, 2026
Download matching recalls as CSV
CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.
Filters
Metric
View
A chart of recalls grouped by month.
Download CSVSummary (Year to date)
- 1,739 recalls have been announced year to date.
- Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
- The highest complete period was Jun 2026 (300).
- Oct 2026 is incomplete and not included in the figures above.
- Complete data
- Incomplete
A bar chart of the total number of recalls in this dataset by recall class.
| Class | Recalls |
|---|---|
| Class II | 24,397 |
| Class I | 9,852 |
| Class III | 2,897 |
| Not Yet Classified | 2 |
| Class | Recalls |
|---|---|
| Class II | 24,397 |
| Class I | 9,852 |
| Class III | 2,897 |
| Not Yet Classified | 2 |
FDA Recall United States TerminatedTerminated: March 17, 2026Historical recordClass II
Reisman Bros Bakery
- Product
- Reisman's Chocolate Snack 3 oz.
- Reason
- Undeclared wheat and soy
- Published
- August 6, 2025
- Distribution
- Multiple states
FDA Recall United States TerminatedTerminated: March 17, 2026Historical recordClass II
Reisman Bros Bakery
- Product
- Reisman's Vanilla Croissants 3 oz.
- Reason
- Undeclared wheat
- Published
- August 6, 2025
- Distribution
- Multiple states
FDA Recall United States TerminatedTerminated: March 17, 2026Historical recordClass II
Reisman Bros Bakery
- Product
- Reisman's Cinnamon Croissants 3 oz.
- Reason
- Undeclared wheat and soy
- Published
- August 6, 2025
- Distribution
- Multiple states
FDA Recall United States TerminatedTerminated: March 17, 2026Historical recordClass II
Reisman Bros Bakery
- Product
- Reisman's Chocolate Croissants 3 oz.
- Reason
- Undeclared wheat
- Published
- August 6, 2025
- Distribution
- Multiple states
FDA Recall United States TerminatedTerminated: March 17, 2026Historical recordClass II
Reisman Bros Bakery
- Product
- Reisman's Strawberry Bars 3 oz.
- Reason
- Undeclared wheat
- Published
- August 6, 2025
- Distribution
- Multiple states
FDA Recall United States TerminatedTerminated: March 17, 2026Historical recordClass II
Reisman Bros Bakery
- Product
- Reisman's Cappuccino Bars 3 oz.
- Reason
- Undeclared wheat and soy
- Published
- August 6, 2025
- Distribution
- Multiple states
FDA Recall United States TerminatedTerminated: March 17, 2026Historical recordClass II
Reisman Bros Bakery
- Product
- Reisman's Fudge Bars 3 oz.
- Reason
- Undeclared wheat and soy
- Published
- August 6, 2025
- Distribution
- Multiple states
FDA Recall United States TerminatedTerminated: March 17, 2026Historical recordClass II
Reisman Bros Bakery
- Product
- Reisman's Brownie Bars 3 oz.
- Reason
- Undeclared wheat and soy
- Published
- August 6, 2025
- Distribution
- Multiple states
FDA Recall United States TerminatedTerminated: March 17, 2026Historical recordClass II
Reisman Bros Bakery
- Product
- Reisman's Jumbo Pink & White Cookies 3 oz.
- Reason
- Undeclared wheat
- Published
- August 6, 2025
- Distribution
- Multiple states
FDA Recall United States TerminatedTerminated: March 17, 2026Historical recordClass II
Reisman Bros Bakery
- Product
- Reisman's Jumbo Black & White Cookies 3 oz.
- Reason
- Undeclared wheat
- Published
- August 6, 2025
- Distribution
- Multiple states
FDA Recall United States TerminatedTerminated: March 17, 2026Historical recordClass II
Reisman Bros Bakery
- Product
- Reisman's Jumbo Chocolate Chip Cookies 3 oz.
- Reason
- Undeclared wheat
- Published
- August 6, 2025
- Distribution
- Multiple states
FDA Recall United States TerminatedTerminated: March 17, 2026Historical recordClass II
Reisman Bros Bakery
- Product
- Reisman's Jumbo Colored Sprinkles Cookies 3 oz.
- Reason
- Undeclared wheat and soy
- Published
- August 6, 2025
- Distribution
- Multiple states
FDA Recall United States TerminatedTerminated: January 9, 2026Historical recordClass II
Camerican International Inc
- Product
- Casa Mamita, Churro Bites Filled with Chocolate Hazelnut Cre…
- Reason
- Undeclared Allergen (Milk). Consumer found a breaded halloumi Cheese Stick in the bag of churro bites. The Halloumi Cheese contains milk which is not an allergen in the churros.
- Published
- August 6, 2025
- Distribution
- The recalled product was distributed to…
FDA Recall OngoingHistorical recordClass II
Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)
- Reason
- Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.
- Published
- July 30, 2025
- Distribution
- Nationwide
FDA Recall OngoingHistorical recordClass II
BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.
- Reason
- CGMP Deviations; potential temperature excursions due to transit delays
- Published
- July 30, 2025
- Distribution
- Within the U.S - OH, VA, FL.
FDA Recall OngoingHistorical recordClass II
EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-880-02.
- Reason
- CGMP Deviations; potential temperature excursions due to transit delays
- Published
- July 30, 2025
- Distribution
- Within the U.S - OH, VA, FL.
FDA Recall OngoingHistorical recordClass II
PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-710-21
- Reason
- CGMP Deviations; potential temperature excursions due to transit delays
- Published
- July 30, 2025
- Distribution
- Within the U.S - OH, VA, FL.
FDA Recall TerminatedTerminated: January 5, 2026Historical recordClass II
clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108, NDC# 68180-492-01
- Reason
- Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.
- Published
- July 30, 2025
- Distribution
- Nationwide
FDA Recall CompletedHistorical recordClass III
Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per carton, Rx Only, Imprimis NJOF, LLC, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-733-05.
- Reason
- Sub-Potent Drug: Subpotent assay results during stability testing.
- Published
- July 30, 2025
- Distribution
- Nationwide
Data last updated:
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.
